Bharat’s Phase II/III Covaxin trial shows safety in children
Vaccine-linked cases of AEFIs such as myocarditis, blood clots and pericarditis were not found with Covaxin.
India
Latest in
India
BioDev, ACTS form partnership to offer trials from India and Africa
The companies will invest to develop an eco-system of uniform LMS, QMS, CTMS tools to offer a smooth experience to…
TCS introduces monitoring solution for clinical trials
The solution enables biopharmaceutical and CROs to detect risks linked to trials and sites using improved statistical algorithms.
Akston doses first volunteers in Phase II/III Covid-19 vaccine trial
Assessing the safety, tolerability and humoral immunogenicity profile of the vaccine at day 56 is the study’s primary objective.
Major depressive disorder: where are the top clinical trial locations?
There is an emerging trend of specific sponsor types running MDD trials, as well as such studies embracing decentralisation.
By
Bharat Biotech to start Phase III intranasal Covid-19 booster trial
The company will conduct the trials at nine study centres, including sites in All India Institute of Medical Sciences.
Bharat Biotech reports positive data from Covid-19 booster dose trial
Antibody titers at day 28 following the booster vaccine were greater than those reported after the primary series.
Bharat Biotech obtains approval to begin intranasal vaccine trials in India
The trials of the intranasal shot will enrol 5,000 healthy subjects who already received their primary vaccine regimen.
By